Vis enkel innførsel

dc.contributor.authorGyurászová, Marianna
dc.contributor.authorGurecká, Radana
dc.contributor.authorBabickova, Janka
dc.contributor.authorTóthová, Ľubomíra
dc.date.accessioned2021-04-12T09:30:16Z
dc.date.available2021-04-12T09:30:16Z
dc.date.created2020-04-20T13:20:44Z
dc.date.issued2020
dc.PublishedOxidative Medicine and Cellular Longevity. 2020, 2020:5478708 1-11.
dc.identifier.issn1942-0900
dc.identifier.urihttps://hdl.handle.net/11250/2737258
dc.description.abstractKidney disease represents a serious global health problem. One of the main concerns is its late diagnosis, only feasible in a progressed disease state. The lack of a clinical manifestation in the early stages and the fact that the commonly measured parameters of renal function are markedly reduced only during advanced stages of the disease are the main cause. Changes at the molecular level of the kidney tissue occur even before nitrogenous substances, such as creatinine and urea, start to accumulate in the blood. Renal proximal tubules contain a large number of mitochondria and are critical for the energy-demanding process of reabsorption of water and solutes. Mitochondria are the largest producers of oxygen radicals, which, in turn, increase the susceptibility of kidneys to oxidative stress-induced damage. Free radicals and prooxidants produced during acute or chronic kidney injury may further aggravate the course of the disease and play a role in the pathogenesis of subsequent complications. Prevention might be the solution in CKD, but patients are often reluctant to undergo preventive examinations. Noninvasive markers and the possibility to obtain samples at home might help to increase compliance. This review will provide an overview of the possible uses of markers of oxidative status in noninvasive biofluids in patients with renal disease.en_US
dc.language.isoengen_US
dc.publisherHindawien_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleOxidative Stress in the Pathophysiology of Kidney Disease: Implications for Noninvasive Monitoring and Identification of Biomarkersen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2020 Marianna Gyurászová et al.en_US
dc.source.articlenumber5478708en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1155/2020/5478708
dc.identifier.cristin1807130
dc.source.journalOxidative Medicine and Cellular Longevityen_US
dc.source.402020:5478708
dc.identifier.citationOxidative Medicine and Cellular Longevity. 2020, 5478708.en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal